Schoenenberger and Marcel Monnier University of Basel, Switzerland Primary Benefits Significantly improves delta-wave deep sleep, reduces nighttime awakenings, and helps establish healthy sleep patternsdemonstrated in multiple human clinical trials Documented stress-protective properties that help the body handle daily pressures while improving overall coping ability and resilience Described as 'incredibly safe' in research literature with no lethal dose identified in animal studies and minimal side effects in human trials spanning decades Amino Acid Sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (WAGGDASGE) Dosing How much do I take
10.1523/JNEUROSCI.6569-10.2011 J
c-MET pathway acts on several downstream effectors including phospholipase C gamma (PLC), cellular Src kinase (c-Src), phosphotidylinsitol-3-OH kinase (PI3K), alpha serine/threonine-protein kinase (Akt), mitogen-activated protein kinase (MAPK), and wingless-related integration site (Wnt) pathways
Abstract Since the discovery of EDS, five different classification systems have been used by clinicians
Evening dosing is generally avoided since some patients report disturbed sleep onset after taking AOD 9604 late in the day
